Get access

Office-based spirometry for early detection of obstructive lung disease

Authors

  • Laura D Wallace MS, ARNP-C,

    (Nurse Practitioner), Corresponding author
    1. Division of Cardiology, The Heart and Vascular Institute of Florida, Morton Plant Hospital, Clearwater, Florida
    Search for more papers by this author
  • Kenneth E Troy MS, ARNP, FNP-C

    (Nurse Practitioner)
    1. Division of Pulmonary Diseases, Critical Care and Internal Medicine, Bay Area Chest Physicians, Morton Plant Hospital, Clearwater, Florida
    Search for more papers by this author

Laura D. Wallace, MS, ARNP-C, The Heart and Vascular Institute of Florida, 455 Pinellas Street, Suite 330, Clearwater, FL 33756. E-mail: lwallace@havi-north.com

Abstract

Purpose: To review the research-based evidence supporting smoking cessation as the only proven method to reduce chronic obstructive pulmonary disease (COPD) progression and to show that early detection of disease with office-based spirometry can lead to therapeutic intervention before physiologic symptoms arise.

Data sources: Extensive review of national and international scientific literature supplemented with drawings and algorithms.

Conclusions: Early detection of COPD with spirometry, along with smoking cessation, and aggressive intervention can alter the insidious course of this highly preventable disease. It is imperative that nurse practitioners utilize this simple and inexpensive procedure to identify COPD in its earliest stages, so treatment can reduce individual and community disease burden, reduce morbidity and mortality, and help reduce healthcare costs.

Implications for practice: Determination of early airflow obstruction supports smoking cessation education, provides objective data for patient motivation, thereby doubling patient compliance and reducing further disease burden.

Ancillary